πŸ‡ΊπŸ‡Έ FDA
Patent

US 11331395

Hydrogel prodrug for treatment

granted A61KA61K31/195A61K31/197

Quick answer

US patent 11331395 (Hydrogel prodrug for treatment) held by Viking Scientific, Inc. expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Viking Scientific, Inc.
Grant date
Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/198, A61K31/245